AbCellera Biologics Inc - ABCL - stock price prediction, stock price target, analyst ratings from 8 analysts

AbCellera Biologics Inc has a share price target of US$ 9, revenue growth forecast of 18.2%, and profit growth estimate of -10.7% for FY25, based on top 8 analyst calls.